Back to Journals » Lung Cancer: Targets and Therapy » Volume 9

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Total article views   Abstract views HTML views PDF downloads Totals
1,672 Dovepress* 1,392 148+ 322 1,540
PubMed Central* 0 132 45 132
Totals 1,392 280 367 1,672
*Since 8 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar